BRKR
Bruker Corporation · Healthcare · Medical - Devices
Momentum inputs (comparable managers):
holder breadth -15.4% ·
share flow +10.0% ·
net new positions -18.2%
· formula
Concentrated accumulation: rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 38.48K | $1.97M | n/a | n/a |
| Q2 2026 | 119 | +10 | 81.03M | $4.87B | +18 | −7 |
| Q1 2026 | 111 | -2 | 77.83M | $2.81B | +8 | −11 |
| Q4 2025 | 114 | +1 | 81.30M | $3.83B | +4 | −2 |
| Q3 2025 | 19 | 0 | 49.38M | $1.60B | +3 | −4 |
| Q2 2025 | 17 | +3 | 44.89M | $1.85B | +4 | −1 |
| Q1 2025 | 11 | 0 | 11.41M | $475.20M | +3 | −3 |
| Q4 2024 | 11 | -2 | 10.42M | $610.89M | +1 | −3 |
| Q3 2024 | 12 | -1 | 5.68M | $392.44M | n/a | −1 |
| Q2 2024 | 13 | n/a | 8.60M | $549.04M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 3.79M | n/a | $222.42M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.01M | +1.0% | $118.08M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (passive) | 1.08M | -5.0% | $63.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | AQR Capital Management ✦ | 890.09K | +18.7% | $52.18M | 0.1% | ▲ Add | 3 | SEC ↗ ×4 |
| 5 | Marshall Wace ✦ | 783.99K | +4510.3% | $45.96M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 605.87K | +2553.0% | $35.52M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 7 | T. Rowe Price ✦ | 549.49K | +3.8% | $32.21M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | Two Sigma Investments ✦ | 516.23K | +129.5% | $30.26M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 9 | Gotham Asset Management ✦ | 106.32K | +146.7% | $6.23M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 10 | Scion Asset Management ✦ | 75.00K | New | $4.40M | 5.7% | New | 1 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 4.54K | -28.9% | $265,900 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Scion Asset Management | $4.40M | 5.7% |
Exited
| Millennium Management | $48.99M | was 0.0% |
| Point72 Asset Management | $16.84M | was 0.1% |
| Arrowstreet Capital | $204,556 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 339 holders, 136.43M shares, $4.78B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 2.00K sh · $105,740
Officer · 3.47K sh · $197,614
Officer · 2.00K sh · $115,200
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology